Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
AIDS (London, England)|December 22, 1999
Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations. Aquitaine Cohort, France, 1996-1998. Groupe dEpidémiologie Clinique de Sida en Aquitaine (GECSA)M Savès, S Vandentorren, V Daucourt, et al.
Gastrointestinal Endoscopy|December 31, 1998
Diagnosis of choledocholithiasis: EUS or magnetic resonance cholangiography? A prospective controlled studyV de Lédinghen, R Lecesne, J M Raymond, et al.
Presse Medicale (Paris, France : 1983)|November 16, 1991
[Possible sexual transmission of hepatitis C virus]L Schouler, F Dumas, F Mesnier, et al.
Hepatology (Baltimore, Md.)|May 29, 2000
Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis CS Pol, B Nalpas, M Bourlière, et al.
Endoscopy|September 1, 1996
Tolerance, effectiveness, and acceptability of sulfate-free electrolyte lavage solution for colon cleaning before colonoscopyJ M Raymond, R Beyssac, E Capdenat, et al.
Alimentary Pharmacology & Therapeutics|January 18, 2011
Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriersL Castéra, P-H Bernard, B Le Bail, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2006
Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis CL Castera, A Constant, C Henry, et al.
Investigative Radiology|March 20, 1999
Segmented 5 versus nonsegmented flow quantitation: comparison of portal vein flow measurementsE Laffon, R Lecesne, V De Ledinghen, et al.
Gut|July 16, 2005
Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective studyJ Foucher, E Chanteloup, J Vergniol, et al.
Alimentary Pharmacology & Therapeutics|June 16, 2009
Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis CD Breilh, J Foucher, L Castéra, et al.
Pageof 8